Cardiac-specific sympathetic activation in men and women with and without heart failure

Heart

Volumn 97, Issue 5, 2011, Pages 382-387

  Mitoff, Peter R ^a   Gam, Daniel ^a   Ivanov, Joan ^a   Al hesayen, Abdul ^a,b   Azevedo, Eduardo R ^a   Newton, Gary E ^a   Parker, John D ^a   Mak, Susanna ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY SINUS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN UPTAKE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPATHETIC TONE;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NOREPINEPHRINE; RETROSPECTIVE STUDIES; SEX FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79751528172     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.199760     Document Type: Article

References (42)

1. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23. (Pubitemid 14035089)
2. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-63.
3. Esler M, Lambert G, Brunner-La Rocca HP, et al. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 2003;177:275-84. (Pubitemid 36337629)
4. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21. (Pubitemid 16081418)
5. Brunner-La Rocca HP, Esler MD, Jennings GL, et al. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001;22:1136-43. (Pubitemid 32666655)
6. Yamasaki Y, Kodama M, Matsuhisa M, et al. Diurnal heart rate variability in healthy subjects: effects of aging and sex difference. Am J Physiol 1996;271:H303-10.
7. Tank J, Diedrich A, Szczech E, et al. Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men. Hypertension 2005;45:1159-64. (Pubitemid 40770321)
8. Umetani K, Singer DH, McCraty R, et al. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 1998;31:593-601. (Pubitemid 28144127)
9. Sevre K, Lefrandt JD, Nordby G, et al. Autonomic function in hypertensive and normotensive subjects: the importance of gender. Hypertension 2001;37:1351-6. (Pubitemid 34225373)
10. Christou DD, Jones PP, Jordan J, et al. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation 2005;111:494-8. (Pubitemid 40204435)
11. Al Hesayen A, Azevedo ER, Newton GE, et al. The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol 2002;39:1269-74. (Pubitemid 34297865)
12. Al Hesayen A, Floras JS, Parker JD. The effects of intravenous sildenafil on hemodynamics and cardiac sympathetic activity in chronic human heart failure. Eur J Heart Fail 2006;8:864-8. (Pubitemid 44794484)
13. Azevedo ER, Kubo T, Mak S, et al. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001;104:2194-9. (Pubitemid 33043299)
14. Azevedo ER, Parker JD. Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. Circulation 1999;100:274-9. (Pubitemid 29340134)
15. Azevedo ER, Newton GE, Floras JS, et al. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation 2000;101:2053-9. (Pubitemid 30233168)
16. 1-selective and nonselective β-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation 1999;94:353-8.
17. Newton GE, Parker JD. Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure. Circulation 1996;94:3161-7.
18. Newton GE, Tong JH, Schofield AM, et al. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol 1996;28:155-61. (Pubitemid 26266635)
19. Newton GE, Azevedo ER, Parker JD. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study. Circulation 1999;99:2402-7. (Pubitemid 29218235)
20. Newton GE, Parker AB, Landzberg JS, et al. Muscarinic receptor modulation of basal and b-adrenergic stimulated function of the failing human left ventricle. J Clin Invest 1996;98:2756-63. (Pubitemid 26427402)
21. Parker JD, Newton GE, Landzberg JS, et al. Functional significance of presynaptic α-adrenergic receptors in failing and nonfailing human left ventricle. Circulation 1995;92:1793-800.
22. Ganz W, Tamura K, Marcus HS, et al. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971;44:181-95.
23. Schroeder C, Adams F, Boschmann M, et al. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am J Physiol Regul Integr Comp Physiol 2004;286:R851-6.
24. Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990;70:963-85. (Pubitemid 20364820)
25. Esler M, Jennings G, Korner P, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3-20. (Pubitemid 18086305)
26. McCance AJ, Forfar JC. Cardiac and whole body [3H]noradrenaline kinetics in ischaemic heart disease: contrast between unstable anginal syndromes and pacing induced ischaemia. Br Heart J 1989;61:238-47. (Pubitemid 19088470)
27. Esler M, Jennings G, Korner P, et al. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984;247:E21-8.
28. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340:618-26. (Pubitemid 29093722)
29. Mitoff PR, Al Hesayen A, Azevedo E, et al. Sex differences in basal hemodynamics and left ventricular function in humans with and without heart failure. Am Heart J 2007;154:575-80. (Pubitemid 47268239)
30. Anon. Exploring the biological contributions to human health: does sex matter? Washington, D.C: National Academies Press, 2001.
31. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176:S1-44.
32. Rumantir MS, Kaye DM, Jennings GL, et al. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 2000;36:824-9.
33. Hayward CS, Kalnins WV, Kelly RP. Gender-related differences in left ventricular chamber function. Cardiovasc Res 2001;49:340-50.
34. Chung AK, Das SR, Leonard D, et al. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation 2006;113:1597-604. (Pubitemid 43739419)
35. Schlaich MP, Kaye DM, Lambert E, et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003;108:560-5. (Pubitemid 36961170)
36. Mendes LA, Davidoff R, Cupples LA, et al. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 1997;134:207-12. (Pubitemid 27406682)
37. Van Spall HG, Roberts JD, Sawka AM, et al. Not a broken heart. Lancet 2007;370:628. (Pubitemid 47247856)
38. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48. (Pubitemid 40204667)
39. Hogarth AJ, Graham LN, Mary DA, et al. Gender differences in sympathetic neural activation following uncomplicated acute myocardial infarction. Eur Heart J 2009;30:1764-70.
40. Ghali JK, Pina IL, Gottlieb SS, et al. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002;105:1585-91. (Pubitemid 34297637)
41. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50. (Pubitemid 38944258)
42. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 2006;113:799-805.